UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer

Gynecologic oncology, 2015-08, Vol.138 (2), p.352-357

2015

Volltextzugriff (PDF)

Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator

Gynecologic oncology reports, 2015-01, Vol.11 (C), p.10-12

2015

Volltextzugriff (PDF)

Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer

Oncotarget, 2015-05, Vol.6 (13), p.11310-11326

2015

Volltextzugriff (PDF)

Quality of life in ovarian cancer

Cancer control, 2011-01, Vol.18 (1), p.52-58

2011

Volltextzugriff (PDF)

Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression

Gynecologic oncology, 2012-09, Vol.126 (3), p.408-412

2012

Volltextzugriff (PDF)

Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use

International journal of gynecological cancer, 2016-10, Vol.26 (8), p.1440-1447

2016

Volltextzugriff (PDF)

Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study

International journal of gynecological cancer, 2015-11, Vol.25 (9), p.1587-1592

2015

Volltextzugriff (PDF)

Evaluation of satisfaction with work–life balance among U.S. Gynecologic Oncology fellows: A cross-sectional study

Gynecologic oncology reports, 2016-04, Vol.16, p.17-20

2016

Volltextzugriff (PDF)

Quality of Life in Ovarian Cancer

Cancer control, 2011-01, Vol.18 (1), p.52-58

2011

Volltextzugriff (PDF)

Weekly topotecan and biweekly bevacizumab in recurrent and progressive ovarian carcinoma: A single institution experience for third-line or greater treatment

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e16553-e16553

2013

Volltextzugriff (PDF)

Pretreatment serum mitochondrial DNA (mtDNA) correlates with shorter progression-free and overall survival in patients with advanced ovarian cancer (OC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5545-5545

2014

Volltextzugriff (PDF)

Effect of cell-free ascites containing mitochondrial DNA (mtDNA) from ovarian cancer (OC) patients on human neutrophils and neutrophil extracellular traps (NETs)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e22087-e22087

2014

Volltextzugriff (PDF)

Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use

International journal of gynecological cancer, 2016-10, Vol.26 (8), p.1440

2016

Volltextzugriff (PDF)

Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator

Gynecologic oncology reports, 2015, Vol.11, p.10-12

2015

Volltextzugriff (PDF)

Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies (2297)

Gynecologic oncology, 2023-09, Vol.176, p.S313-S314

2023

Volltextzugriff (PDF)

ctDNA in treatment response monitoring in patients with relapsed gynecologic malignancies

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17501-e17501

2022

Volltextzugriff (PDF)

2022-RA-968-ESGO Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A410-A411

2022

Volltextzugriff (PDF)

Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report

Gynecologic oncology reports, 2015-11, Vol.14 (C), p.6-8

2015

Volltextzugriff (PDF)

Use of common analgesics is not associated with ovarian cancer survival

Cancer epidemiology, biomarkers & prevention, 2015-08, Vol.24 (8), p.1291-1294

2015

Volltextzugriff (PDF)

Assessment of internet-based information regarding pelvic organ prolapse and urinary incontinence

Female pelvic medicine & reconstructive surgery, 2012-01, Vol.18 (1), p.50-54

2012

Volltextzugriff (PDF)

Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report

Gynecologic oncology reports, 2015, Vol.14, p.6-8

2015

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)
Berichte
(2)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Female
(9)
Humans
(9)
Obstetrics & Gynecology
(8)
Oncology
(8)
Middle Aged
(6)
Hematology, Oncology And Palliative Medicine
(5)
Obstetrics And Gynecology
(5)
Ovarian Cancer
(5)
Adult
(4)
Aged
(4)
Carcinoma, Ovarian Epithelial
(4)
Aged, 80 And Over
(3)
Ascites
(2)
Ascites - Immunology
(2)
Ascites - Pathology
(2)
Case Report
(2)
Cell Proliferation
(2)
Endometrial Cancer
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer

Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer

Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator

Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer

Quality of life in ovarian cancer

Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expression

Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use

Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study

Evaluation of satisfaction with work–life balance among U.S. Gynecologic Oncology fellows: A cross-sectional study

Quality of Life in Ovarian Cancer

Weekly topotecan and biweekly bevacizumab in recurrent and progressive ovarian carcinoma: A single institution experience for third-line or greater treatment

Pretreatment serum mitochondrial DNA (mtDNA) correlates with shorter progression-free and overall survival in patients with advanced ovarian cancer (OC)

Effect of cell-free ascites containing mitochondrial DNA (mtDNA) from ovarian cancer (OC) patients on human neutrophils and neutrophil extracellular traps (NETs)

Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use

Malignant peritoneal mesothelioma without asbestos exposure: An ovarian cancer imitator

Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies (2297)

ctDNA in treatment response monitoring in patients with relapsed gynecologic malignancies

2022-RA-968-ESGO Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies

Poorly differentiated Sertoli–Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report

Use of common analgesics is not associated with ovarian cancer survival

Assessment of internet-based information regarding pelvic organ prolapse and urinary incontinence

Poorly differentiated Sertoli-Leydig tumor with heterologous, high-grade, sarcomatoid features: A case report

Suchergebnisse filtern